Host-microbe interactions are crucial for normal physiological and immune system development and are 9 implicated in a wide variety of diseases, including inflammatory bowel disease (IBD), obesity, colorectal 10 cancer (CRC), and type 2 diabetes (T2D). Despite large-scale case-control studies aimed at identifying 11 microbial taxa or specific genes involved in pathogeneses, the mechanisms linking them to disease have 12 thus far remained elusive. To identify potential mechanisms through which human-associated bacteria 13
Main Text 25
Metagenomic case-control studies of the human gut microbiome have implicated bacterial genes in a 26 myriad of diseases. Yet, the sheer diversity of genes within the microbiome (1) and the lack of functional 27 annotations (2) have thwarted efforts to identify the mechanisms by which bacterial genes impact host 28
health. In the cases where functional annotations exist, they tend to reflect the proteins' most granular 29 molecular functions (e.g. DNA binding, post-translational modification) rather than their role in 30 biological pathways (3) and few, if any, relate to host cell signaling and homeostasis. Associating any 31
commensal bacterial gene and a host pathway has thus far required experimental approaches catered to 32 each gene or gene function (4, 5). 33
Protein-protein interactions (PPIs) have revealed the mechanisms by which pathogens interact with host 34 tissue through in-depth structural studies of individual proteins (5-7), as well as large-scale whole-35 organism interaction screens (8, 9) . We hypothesized that host-microbiome PPIs may underlie health 36 status and could serve to provide additional information, through annotation of human pathways, about 37 the role of bacteria in modulating health. There are already canonical examples of protein-mediated 38 microbe-associated patterns (MAMPs) that directly trigger host-signaling pathways through pattern 39 recognition receptors present on epithelial and immune tissues (10), such as flagellin with Toll-like 40
receptor 5 (TLR5). Several recent observations have further underscored a role for commensal-host PPIs 41
in health: a protease secreted by Enterococcus faecalis binds incretin hormone glucagon-like peptide 1 42
(GLP-1), a therapeutic target for type 2 diabetes (T2D) (11); and a slew of ubiquitin mimics encoded by 43 both pathogens (12) and gut commensals (13) play a role in modulating membrane trafficking. 44
Currently, few experimentally-verified PPIs exist between bacterial and human proteins (roughly 8,000 in 45
the IntAct database (14)) and only a handful of these involve proteins pulled from the human gut 46 microbiome. Expanding the commensal-human interaction network through state-of-the-art structural 47 modeling (15) is untenable, as there are few sequences homologous to genes found in metagenomes 48
represented in co-crystals from the Protein Data Bank (16) (PDB) ( Fig. S1 , Supplementary Note 1). In the 49 absence of structure and experimental data, sequence identity methods have been used to great effect to 50 infer host-pathogen PPI networks for single pathogens (17-19), but such approaches have not yet been 51 applied at the community-level, as would be required for the human gut microbiome. 52
All pathogen-host interactions are initially implicated in virulence, whereas microbiome-associated 53 disorders tend not to follow Koch's postulates (20) . To distinguish PPIs that may be associated with 54
health versus disease, we compared community-level PPI profiles in large case-control cohorts of well-55 established microbiome-associated disorders-namely colorectal cancer (CRC) (21-24), T2D (25, 26), 56 inflammatory bowel disease (IBD) (27) and obesity (28) ( Fig. 1A , Table S1 ). In order to build 57 community-level PPI profiles, we mapped quality-filtered metagenomic sequencing reads from eight 58 studies to a newly constructed database of bacterial human-protein interactors and the bacterial members 59 of their associated UniRef clusters ( Fig. S2, Supplementary Methods) , which represent homeomorphic 60 protein superfamilies through sequence identity (29). Using a normalized feature importance ranking 61 from random forest classifiers trained on each disease cohort ( Fig. S3 , Supplementary Methods), we find 62 46,734 commensal bacterial proteins (comprising 579 clusters) associated with disease, by virtue of their 63 putative interactions with 1,145 human proteins. 64 1  1  1  2  2  13  15  20  21  32  33  41  55  59  69  71  81  106  115  134  185  291  373 Interaction does not need to be conserved across homologous proteins in different bacterial species. A key 80
concern is the disproportionate number of bacteria-human PPIs in IntAct derived from high-throughput 81 screens performed on three intracellular pathogens: Yersinia pestis, Francisella tularensis and Bacillus 82 anthracis (8). However, we find that patient-detected bacterial clusters are not biased towards the 83 originating classes of these three pathogens-Bacilli or Gammaproteobacteria-and rather, reflect the 84 breadth of taxa typically associated with human gut microbiomes ( Fig. 1C and S4 ). We verified that 85 human microbiome proteins have high amino-acid similarity to experimentally-verified human interactors 86
in the same UniRef cluster ( Fig. 1C and S5 ). Additionally, interspecies bacterial-human protein interface 87 residues, in general, are highly similar, or even identical, between members of the same UniRef cluster 88 ( Fig. S6 , Supplementary Note 2). Although we appreciate that there will be commensal-human PPIs that 89 are not captured by this approach due to the limited scope of experimental data available, this is the 90 largest and only dataset of microbiome-host associated PPIs. 91 Surprisingly, the 816 human proteins we associate with CRC via the microbiome contain a number of 92 previously identified CRC-associated genetic loci, including well-known cancer genes: tumor protein 93 p53, epidermal growth factor receptor (EGFR), matrix metalloprotease 2 (MMP2), and insulin-like 94 growth factor-binding protein 3 (IGFBP3), among others ( Fig. 1D ). This represents a larger trend: the 95 1,145 human interactors are overall enriched for proteins with previously-reported gene-disease 96 associations (GDA) in CRC, T2D, and IBD ( Fig. 1E , Table S2 ), with the exception of obesity, where 97
annotation is generally scarce. In line with mixed etiologies of diseases, we see that GDAs are not 98 disease-cohort specific (Fig. S7 ). In fact, 36 percent of our genes have more than one GDA for our 99 diseases of interest. We suspected this may extend to autoimmune diseases, which are increasingly 100 studied in the context of the gut microbiome (30), and we confirm enrichment of GDAs for autoimmune 101 disorders in the human proteins implicated by our method. This concordance between known disease 102 annotation and disease association through our method increases our confidence that we are capturing 103 relevant molecular heterogeneity underlying microbiome-related disease. 104
If these bacterial proteins are indeed modulating human health through PPIs, we should expect them to 105 contain signatures of surface localization or secretion. We find that a majority of disease-associated 106 bacterial protein clusters (90.2%) contain proteins that are transmembrane, are secreted by type 3 or type 107 4 secretion systems, and/or contain eukaryotic-like domains, another marker for secretion ( Fig. 1F ). The 108 remaining 9.8% may also be adequately localized, but our annotations do not cover all bacterial secretion 109 systems, and it is unclear whether bacterial lysis may result in protein delivery to the host. 110
One of the major advantages of our work is that through this new interaction network, we vastly improve 111 our ability to annotate host-relevant microbiome functions. 35.8% of our disease-associated bacterial 112 clusters contain no members with annotated microbial pathways in KEGG (Kyoto Encyclopedia of Genes 113
and Genomes) (31) ( Fig. 2A ). Yet, most of these genes can now be annotated according to the pathways 114 of their human targets, obtaining a putative disease-relevant molecular mechanism ( Fig. 2B ).
115
Interestingly, most of the bacterial clusters with KEGG pathway annotations also gain a secondary human 116 pathway annotation. This dual function is not entirely surprising, as a number of these have orthologs that 117
have been previously identified as bacterial 'moonlighting' proteins, which perform secondary functions 118 in addition to their primary role in the cell (32 In evaluating the statistical significance of recurrent human functional annotations, we performed 136 pathway enrichment analysis on the implicated human proteins and find proteins with established roles in 137 cellular pathways coherent with the pathophysiology of CRC, IBD, obesity and T2D (Fig. 2C ), namely 138 those involving immune system, apoptosis, oncogenesis, and endocrine signaling pathways. Though most 139 enriched pathways include human proteins associated with all four diseases, reflecting their associated 140
relative risks (37-41), there is heterogeneity in the identity and number of members associated with each 141 study. Far more human proteins from the antigen presentation pathway are associated with T2D, obesity 142
and IBD cohorts' microbiomes than with CRC, perhaps indicating a disease-specific association with this 143 process. We see this again with CRC, in the death receptor signaling pathway and remodeling of 144 epithelial adherens junctions. 145
We These data suggest a set of discrete protein interactions that induce physiological effects when delivered 163 to the host. Consistent with this idea, we find that indeed many associated human proteins are known drug 164
targets (Table S3 ). For example, both T2D cohorts' and the obesity cohort's microbiomes independently 165
implicate human protein Rev-ErbA alpha (NR1D1), the target of the drugs GSK4112, SR9009 and 166 SR9011, which inhibit the binding of Rev-ErbA alpha with its natural ligand, heme (Fig. 3A) . These 167 drugs have been shown to affect cellular metabolism in vitro and affect hyperglycaemia when given to 168 mouse models of metabolic disorder (46, 47). We also find instances where the off-label effects or side 169 effects associated with the drug match our microbiome-driven human protein association. For instance, 170
imatinib mesylate (brand name: Gleevec) has several human binding partners, including macrophage 171 colony-stimulating factor 1 receptor (M-CSF1R) ( Fig. 3B on imatinib supports these findings: although imatinib is best known as a treatment for leukemia, it has 175 been shown to affect glycemic control in patients with T2D (48). Furthermore, imatinib can also halt the 176 proliferation of colonic tumor cells and is involved generally in inflammatory pathways, through its 177 inhibition of TNF-alpha production (49). Whereas the notion of microbiome-derived metabolites acting as 178 drugs is well-appreciated (50, 51), this work broadens the scope of microbiome-derived drugs to include 179 protein products acting through PPI. 180 Here, we reveal for the first time an extensive host-microbiome PPI landscape. To achieve this, we 186 benefit from existing methods in pathogen-host PPI discovery, further informed by community-level PPI 187
profiles of genes differentially detected in human metagenomes. This work highlights the myriad host 188 mechanisms targeted by the gut microbiome and the extent to which these mechanisms are targeted across 189 microbiome-related disorders. However, this network is far from complete. Few of the interaction studies 190 on which this interaction network is based were performed on commensal bacteria and therefore, we may 191 be missing interactions specific to our intimately associated bacteria. In addition to large-scale PPI studies 192
involving commensal bacteria and their hosts, further in-depth studies will be needed to fully characterize 193 these mechanisms, such as whether these bacterial proteins activate or inhibit their human protein 194
interactors' pathways. 195
This platform enables a high-throughput glimpse into the mechanisms by which microbes impact host 196 tissue, allowing for mechanistic inference and hypothesis generation from any metagenomic dataset. 197
Pinpointing those microbe-derived proteins that interact directly with human proteins will enable the 198 discovery of novel diagnostics and therapeutics for microbiome-driven diseases, more nuanced definitions 199
of the host-relevant functional differences between bacterial strains, and a deeper understanding of the co-200 evolution of humans and other organisms with their commensal microbiota. Paired reads were combined into a single file and aligned to a protein library of all 1,613,641 human-458
interacting bacterial proteins generated above. This read-to-protein alignment was performed using 459
BLASTx through the DIAMOND (53) command line tool (v0.9.24.125). Read alignments were filtered to 460 only consider results with an identity of at least 90% and no gaps. Bacterial proteins were considered 461 detected with sufficient depth and coverage: more than 10 reads across 95% of the protein sequence, 462
excluding 10 amino acids at each terminus. We assign any bacterial protein detection to its corresponding 463
UniRef homology cluster. Human-interacting bacterial clusters are marked as either 'detected' or 'not 464
detected' for each patient in each study. For each patient, we also generate a file of human proteins that 465 are targeted by their detected bacterial proteins based on our bacteria-human PPI network. 466
Identity, similarity, and conservation measurements 467
The sequence identity constraints imposed from a UniRef cluster's seed on all other member sequences 468 don't explicitly provide any information about the sequence identity, or similarity, between other pairs of 469 sequences in the cluster. We compute pairwise alignments in order to understand how appropriate our 470 annotation mapping is between proteins experimentally-verified to interact with human proteins and 471 bacterial members of the same UniRef cluster that were detected in metagenomic samples. 472
Experimentally-verified interactors are aligned to their metagenome-detected UniRef cluster members 473
using the Smith-Waterman local alignment algorithm with a BLOSUM62 matrix via python's parasail 474
(54) library (v.1.1.17). Amino acid identity is calculated as the number of identical matches in the 475 pairwise alignment, divided by the length of the experimentally-verified interactor. Amino acid similarity 476
is likewise calculated as the number of matches in the pairwise alignment that represent frequent 477 substitutions (non-negative BLOSUM62 scores), divided by the length of the experimentally-verified 478
interactor.
480
Each cluster has a different number of bacterial members, and thus, comparisons, so we need to 481 summarize the bacterial identity and similarity metrics per cluster. We represent the identity between 482
experimentally-verified and metagenomic-detected bacterial protein sequences for each cluster as mean, 483 median, or a weighted average (Fig. S5 ). Specifically, we calculate the weighted average of 484 identity/similarity as:
Where Prevalence member is the percent of patients where the bacterial sequence was detected, 489
Prevalence cluster is the percent of patients where any bacterial sequence from the cluster was detected, and 490 %match is either the identity or similarity between the member and the experimentally-verified protein 491
493
When necessary, we constructed multiple sequence alignments using only the experimentally-verified 494
interactor sequence and all the metagenome-detected members of its homology cluster in order to 495 quantify amino acid conservation at each site. We calculated the Jensen-Shannon divergence using the 496 code provided by Capra et al. (55) with a window size of 3. 497 498
Prioritization of disease-associated bacterial protein clusters and human targets 499
In order to identify heterogeneity in the prevalence of bacteria-human PPIs, we preprocessed the data into 500 two detection matrices. Each patient from each study is represented in two feature spaces: (a) a binary 501 vector of detected bacterial gene clusters or (b) a binary vector of putatively targeted human proteins. 502
Human proteins were considered redundant if they shared all the same bacterial protein partners in our 503 database, as their "detection" is, by definition, perfectly correlated in this design, and were treated as a 504 single feature. Additionally, we build a contingency table based on the case/control balance of the dataset 505 and the prevalence of each bacterial gene cluster or human protein. Features with an expected count of 506 less than 5 in any cell of the contingency table were also filtered out as being under-or over-detected. 507
We use these processed matrices to train a random forest machine learning classifier on the task of 508 separating case and control patients and, after verifying that they achieve reasonable performance on the 509 task using leave-one-out cross-validation ( Fig. S3) , we extract the feature importance from the classifiers. 510
Having used the scikit-learn (56) implementation of the random forest algorithm, feature importance 511
corresponds to the average Gini impurity of the feature in all splits that it was involved in. Gini feature 512
importance is a powerful prioritization tool, as it can capture the multivariate feature importance (whereas 513 simple metrics like log-odds ratio and corrected chi-squared statistics only capture univariate feature 514 importance). However, it has been noted that in sparse, binary decision tasks like our own (57, 58), this 515 feature importance can be can overestimate the importance of features based on their prevalence alone. 516
To obtain a normalized Gini feature importance, we perform a Monte Carlo estimate of the expected Gini 517 importance for each feature given the prevalence of all features in that dataset. On each iteration of the 518 simulation, we generate a random null feature matrix using a Bernoulli binary generator where: 519 1 520
We train two random forests on the disease labels for each patient, using either the real matrix or the null 521 matrix. Both real and null Gini feature importances are extracted for each feature and aggregated across 522
iterations of the simulation. The normalized Gini importance for each feature is expressed as a z-score: 523
The simulation is repeated until the distance between the maximum and minimum normalized Gini 525
importance converges (at least 200 iterations of holding equal value). Code and preprocessed detection 526 matrices for each of the studies are provided in the Auxiliary Supplementary Materials. 527
This iterative procedure is a convenient way to generate a null feature importance for comparison, but 528 also provides a very robust measurement of Gini real . Random trees from a random forest act as 529 independent estimators: Given the same data, calculating the average importance of N forests with E 530 estimators is equivalent to the importance on a single forest with N × E estimators. For the real Gini 531 feature importance calculation, our final estimates are equivalent to a forest with I × E trees, where I is the 532 number of iterations at convergence. The entire procedure is analogous to iteratively increasing the 533 number of trained trees in a random forest (and its paired null model) with a step-size E (in our case, 534 E=100) until normalized feature importance converges. An example is provided in the Auxiliary 535
Supplementary Materials. 536
Most of the normalized feature importances across studies fall at or below zero, indicating that their Gini 537 feature importance is not higher than would be expected in the null model (Fig. S8 ). This provides a 538 convenient cutoff (normalized Gini > 0) to prioritize a set of proteins, as human proteins with positive 539
normalized Gini importance capture proteins with large log-odds ratio magnitudes and rescues candidates 540 that would've been missed through univariate analysis. 541 542
Human pathway annotation and enrichment analysis 543
Human pathway annotation was performed using the mygene python library. Specifically, we queried 544 pathway annotations from WikiPathways (59), filtering out pathways from TarBase, as they specifically 545 only include miRNA interaction annotation. 546 547
We performed pathway enrichment analysis using QIAGEN's Ingenuity Pathway Analysis (IPA) (60) 548
tool. All human proteins with a normalized feature importance greater than zero were uploaded as 549
UniProt identifiers into the desktop interface and submitted to their webserver for Core Enrichment 550
Analysis was conducted only on human tissue and cell lines and IPA's stringent evidence filter. Pathways 551
were considered enriched if they had both a -log(p-value) ≥ 1.3 and a Benjamini-Hochberg False 552
Discovery Rate less or equal to 5%. 553 554
We additionally annotated all human proteins with any known drug targets from the probes-and-drugs 555 database (61) (04.2019 database dump), which aggregates drug-target interactions from the largest drug-556 target databases. 557 
755
Depiction of the interaction network inference and protein detection pipeline. Note that only bacterial proteins found to be 756 human-interactors through the mapping procedure are used as candidates for detection in metagenomic studies.
757
Interactions are propagated within UniRef homology clusters Figure S3 . Performance metrics.
758
A heatmap of precision, recall, and F1-scores for random forests with 5000 estimators, evaluated using leave-one-out cross- 
775
The number of human interactors (with normalized feature importance greater than 0) according to their GDAs for CRC, T2D, 776 obesity, IBD and autoimmunity. 
786
Cluster Uniref50_Q1R9K8 contains several bacterial ecotins detected in human metagenomes. Using BLAST, we found high-
787
quality matches between members of this cluster and the structure 1p0s:E (Ecotin precursor M84R) in the PDB (identity of 788 97.2%, eval=1e-75). Our putative interactor to this cluster, coagulation factor X (P00742) likewise matched structure 1p0s:H
789
(coagulation factor X precursor) (identity of 100%, eval=3.8 e-150). Chain E is shown in blue, and chain H in orange, with their 790 interface residues highlighted as spheres. The linear model of both proteins is shown underneath. The linear model's colored 791 areas indicate the part of the proteins that were crystallized in this PDB, while the greyed-out areas indicate non-crystallized 792 spans. The squares indicate the range of the BLAST match between our query proteins and the PDB reference sequences. Finally,
793
ticks on the linear model indicate the location of interface residues as detected in this model. There are currently not enough 794 published structures to perform this analysis on all interactions involving detected bacterial genes (Fig. S1 , Tables S4 and S5 ).
795
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Chain E Supplementary Tables  796   Table S1 . Metagenomic studies used in this research. 797 For each study, we list its disease focus, the labels in the cohort study, the patient count for each of the 798 labels, how we grouped cases and controls, the number of detected bacterial clusters and inferred human 799
interactors, and the number of important bacterial and human proteins with normalized feature importance 800 greater than 0. 801 802 Table S2 . Human interactors that have known gene-disease associations. 803
Listed are the disease-associated human proteins (with normalized feature importance greater than 0) with 804
GDAs in DisGeNET, along with the study in which they are found to be important. 805 806 Table S3 . Human interactors that are known drug targets. 807
For each disease-associated human protein (with normalized feature importance greater than 0), we list 808
the drug interactor and the study in which it was found to be important. 809 810 Table S4 . Interface residues from PDB chain pairs matching human and bacterial interactors in 811 our dataset. 812
All pairs of detected bacterial proteins and human proteins in the eight metagenomic datasets that have 813
BLASTp matches to two different chains within the same PDB cocrystal structure (totaling 15 bacterial 814 protein clusters and 8 human proteins). Listed are the BLAST readouts for both matches, as well as the 815
interface residues for each chain at the PDB index, PDB sequence, and UniProt sequence mappings. 816 817 Table S5 . Cocrystal structures representing interactions in our set.
818
A summary of the PDB chain-pairs (presented in Table S4 ) that can be used as representatives to identify 819
interface residues for interactions in our set. We annotate each interaction by whether the bacterial and 820
human proteins match non-overlapping pairs of chains. 821 822 Table S6 . Gene-disease association comparison statistics. 823
The set sizes, fractions, chi-squared statistics and p-values used to generate Fig. 1E . 824
